相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictors of hepatocellular carcinoma recurrence associated with the use of direct-acting antiviral agent therapy for hepatitis C virus after curative treatment: A prospective multicenter cohort study
Masahito Nakano et al.
CANCER MEDICINE (2019)
Direct-acting antivirals after successful treatment of early hepatocellular carcinoma improve survival in HCV-cirrhotic patients
Giuseppe Cabibbo et al.
JOURNAL OF HEPATOLOGY (2019)
Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection
Elisabetta Degasperi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Amit G. Singal et al.
GASTROENTEROLOGY (2019)
Impact of direct-acting antivirals on early recurrence of HCV-related HCC: Comparison with interferon-based therapy
Mizuki Nishibatake Kinoshita et al.
JOURNAL OF HEPATOLOGY (2019)
The impact of interferon-free direct-acting antivirals on clinical outcome after curative treatment for hepatitis C virus-associated hepatocellular carcinoma: Comparison with interferon-based therapy
Yuko Nagaoki et al.
JOURNAL OF MEDICAL VIROLOGY (2019)
Predictive Factors for Hepatocellular Carcinoma Occurrence or Recurrence after Direct-Acting Antiviral Agents in Patients with Chronic Hepatitis C
Yu Yoshimasu et al.
JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES (2019)
High efficacy of direct-acting anti-viral agents in hepatitis C virus-infected cirrhotic patients with successfully treated hepatocellular carcinoma
M. Persico et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Liver Angiopoietin-2 Is a Key Predictor of De Novo or Recurrent Hepatocellular Cancer After Hepatitis C Virus Direct-Acting Antivirals
Francesca Faillaci et al.
HEPATOLOGY (2018)
Direct-acting antivirals do not increase the risk of hepatocellular carcinoma recurrence after local-regional therapy or liver transplant waitlist dropout
Annsa C. Huang et al.
HEPATOLOGY (2018)
HCV eradication induced by direct-acting antiviral agents reduces the risk of hepatocellular carcinoma
George N. Ioannou et al.
JOURNAL OF HEPATOLOGY (2018)
Increased recurrence rates of hepatocellular carcinoma after DAA therapy in a hepatitis C-infected Egyptian cohort: A comparative analysis
M. El Kassas et al.
JOURNAL OF VIRAL HEPATITIS (2018)
Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group
Toshie Mashiba et al.
PLOS ONE (2018)
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosis
F. Mettke et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
Eradication of Hepatitis C Virus Infection in Patients With Cirrhosis Reduces Risk of Liver and Non-Liver Complications
Pierre Nahon et al.
GASTROENTEROLOGY (2017)
Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression
Reem Waziry et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatic decompensation is the major driver of death in HCV-infected cirrhotic patients with successfully treated early hepatocellular carcinoma
Giuseppe Cabibbo et al.
JOURNAL OF HEPATOLOGY (2017)
Hepatocellular carcinoma decreases the chance of successful hepatitis C virus therapy with direct-acting antivirals
Stacey B. Prenner et al.
JOURNAL OF HEPATOLOGY (2017)
Dropout Rate From the Liver Transplant Waiting List Because of Hepatocellular Carcinoma Progression in Hepatitis C Virus-Infected Patients Treated With Direct-Acting Antivirals
Alberto Zanetto et al.
LIVER TRANSPLANTATION (2017)
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre study
G. Cabibbo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Direct-Acting Antivirals Decreased Tumor Recurrence After Initial Treatment of Hepatitis C Virus-Related Hepatocellular Carcinoma
Kenji Ikeda et al.
DIGESTIVE DISEASES AND SCIENCES (2017)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
Direct acting antiviral therapy and tumor recurrence after liver transplantation for hepatitis C-associated hepatocellular carcinoma
Ju Dong Yang et al.
JOURNAL OF HEPATOLOGY (2016)
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2016)
Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
JOURNAL OF HEPATOLOGY (2016)
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Epidemiology of Hepatocellular Carcinoma in the United States: Where Are We? Where Do We Go?
Hashem B. El-Serag et al.
HEPATOLOGY (2014)
Adjuvant interferon therapy after curative therapy for hepatocellular carcinoma (HCC): A meta-regression approach
Ying-Chun Shen et al.
JOURNAL OF HEPATOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
Prevention of hepatocellular carcinoma recurrence with alpha-interferon after liver resection in HCV cirrhosis
Vincenzo Mazzaferro et al.
HEPATOLOGY (2006)
The prevalence of hepatitis C virus infection in the United States, 1999 through 2002
Gregory L. Armstrong et al.
ANNALS OF INTERNAL MEDICINE (2006)
Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area
YH Huang et al.
LIVER INTERNATIONAL (2005)
Early-stage hepatocellular carcinoma in patients with cirrhosis: Long-term results of percutaneous image-guided radiofrequency ablation
R Lencioni et al.
RADIOLOGY (2005)
Interferon therapy after tumor ablation improves prognosis in patients with hepatocellular carcinoma associated with hepatitis C virus
Y Shiratori et al.
ANNALS OF INTERNAL MEDICINE (2003)
Long-term survival and pattern of recurrence after resection of small hepatocellular carcinoma in patients with preserved liver function - Implications for a strategy of salvage transplantation
RTP Poon et al.
ANNALS OF SURGERY (2002)
分享论文
